Borregaard's operating revenues increased to NOK 2,045 million (NOK 1,949
million)(2) in the 2(nd) quarter of 2025. EBITDA(1) reached NOK 522 million (NOK
510 million). The result in BioSolutions and BioMaterials increased while Fine
Chemicals had a lower result.
Continued growth in sales to agriculture was the main reason for the improved
result in BioSolutions. In BioMaterials, the result increased due to higher
sales prices, improved product mix and increased sales volume, partly offset by
higher wood costs. Lower sales prices for bioethanol were the main reason for
the weaker result in Fine Chemicals. The net currency effects were positive in
all areas.
Profit before tax was NOK 326 million (NOK 322 million). Earnings per share were
NOK 2.56 (NOK 2.45).
We are pleased to report improved results for both BioSolutions and
BioMaterials, driven by continued strong sales to agriculture and price
increases for speciality cellulose, says President and CEO Per A. Sørlie.
Contacts:
Director Investor Relations, Knut-Harald Bakke, +47 905 79 164
SVP Organisation and Public Affairs, Dag Arthur Aasbø, +47 918 34 108
1. Operating profit before depreciation, amortisation and other income and
expenses
2. Figures in parentheses are for the corresponding period in the preceding year
This information is considered to be inside information pursuant to the EU
Market Abuse Regulation and is subject to the disclosure requirements pursuant
to Section 5 - 12 of the Norwegian Securities Trading Act.
This stock exchange announcement was published by Lotte Kvinlaug, Investor
Relations Officer at Borregaard ASA, on 16 July 2025 at 07:00 CEST.